Literature DB >> 23604044

The liver works as a school to educate regulatory immune cells.

Fenglei Li1, Zhigang Tian.   

Abstract

Because of its unique blood supply, the liver maintains a special local immune tolerogenic microenvironment. Moreover, the liver can impart this immune tolerogenic effect on other organs, thus inducing systemic immune tolerance. The network of hepatic regulatory cells is an important mechanism underlying liver tolerance. Many types of liver-resident antigen-presenting cells (APCs) have immune regulatory function, and more importantly, they can also induce the differentiation of circulating immune cells into regulatory cells to further extend systemic tolerance. Thus, the liver can be seen as a type of 'school', where liver APCs function as 'teachers' and circulating immune cells function as 'students.'

Mesh:

Year:  2013        PMID: 23604044      PMCID: PMC4003213          DOI: 10.1038/cmi.2013.7

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  142 in total

1.  NK cells promote islet allograft tolerance via a perforin-dependent mechanism.

Authors:  Joshua N Beilke; Nathan R Kuhl; Luc Van Kaer; Ronald G Gill
Journal:  Nat Med       Date:  2005-09-11       Impact factor: 53.440

2.  Hepatic environment elicits monocyte differentiation into a dendritic cell subset directing Th2 response.

Authors:  Florian Cabillic; Nathalie Rougier; Christelle Basset; Isabelle Lecouillard; Erwann Quelvennec; Louis Toujas; Christiane Guguen-Guillouzo; Anne Corlu
Journal:  J Hepatol       Date:  2005-09-15       Impact factor: 25.083

Review 3.  The liver as an immunological organ.

Authors:  Vito Racanelli; Barbara Rehermann
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

Review 4.  Central tolerance: good but imperfect.

Authors:  Alena M Gallegos; Michael J Bevan
Journal:  Immunol Rev       Date:  2006-02       Impact factor: 12.988

Review 5.  Immunoregulation of autoimmunity by natural killer T cells.

Authors:  Loes Linsen; Veerle Somers; Piet Stinissen
Journal:  Hum Immunol       Date:  2006-03-31       Impact factor: 2.850

6.  Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis.

Authors:  Maria Serena Longhi; Munther J Hussain; Ragai R Mitry; Sunil K Arora; Giorgina Mieli-Vergani; Diego Vergani; Yun Ma
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

7.  Kupffer cell-dependent hepatitis occurs during influenza infection.

Authors:  Noelle K Polakos; Judith C Cornejo; Debbie A Murray; Kate O Wright; John J Treanor; I Nicholas Crispe; David J Topham; Robert H Pierce
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

8.  Cross-presentation of oral antigens by liver sinusoidal endothelial cells leads to CD8 T cell tolerance.

Authors:  Andreas Limmer; Jutta Ohl; Gerhard Wingender; Martina Berg; Frank Jüngerkes; Beatrix Schumak; Dominik Djandji; Kai Scholz; Alexandra Klevenz; Silke Hegenbarth; Frank Momburg; Günter J Hämmerling; Bernd Arnold; Percy A Knolle
Journal:  Eur J Immunol       Date:  2005-10       Impact factor: 5.532

9.  Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.

Authors:  Bo Huang; Ping-Ying Pan; Qingsheng Li; Alice I Sato; David E Levy; Jonathan Bromberg; Celia M Divino; Shu-Hsia Chen
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

10.  Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.

Authors:  Ruth Y Lan; Chunmei Cheng; Zhe-Xiong Lian; Koichi Tsuneyama; Guo-Xiang Yang; Yuki Moritoki; Ya-Hui Chuang; Takafumi Nakamura; Shigeru Saito; Shinji Shimoda; Atsushi Tanaka; Christopher L Bowlus; Yasuo Takano; Aftab A Ansari; Ross L Coppel; M Eric Gershwin
Journal:  Hepatology       Date:  2006-04       Impact factor: 17.425

View more
  33 in total

Review 1.  Contributions of nonhematopoietic cells and mediators to immune responses: implications for immunotoxicology.

Authors:  Barbara L F Kaplan; Jinze Li; John J LaPres; Stephen B Pruett; Peer W F Karmaus
Journal:  Toxicol Sci       Date:  2015-06       Impact factor: 4.849

Review 2.  The role of the liver in sepsis.

Authors:  Jun Yan; Song Li; Shulin Li
Journal:  Int Rev Immunol       Date:  2014-03-10       Impact factor: 5.311

Review 3.  Natural killer cells in liver diseases.

Authors:  Meijuan Zheng; Haoyu Sun; Zhigang Tian
Journal:  Front Med       Date:  2018-04-19       Impact factor: 4.592

4.  A Multi-institutional, Retrospective Analysis of Patients with Metastatic Renal Cell Carcinoma to Bone Treated with Combination Ipilimumab and Nivolumab.

Authors:  Kunal Desai; Landon Brown; Wei Wei; Matthew Tucker; Chester Kao; Emily Kinsey; Brian Rini; Kathryn Beckermann; Tian Zhang; Moshe C Ornstein
Journal:  Target Oncol       Date:  2021-08-11       Impact factor: 4.493

5.  Expression and clinical significance of inhibitory receptor Leukocyte-associated immunoglobulin-like receptor-1 on peripheral blood T cells of chronic hepatitis B patients: A cross-sectional study.

Authors:  Yurong Gu; Yanhua Bi; Huan Wei; Jing Li; Zexuan Huang; Chunhong Liao; Weixin Liao; Yuehua Huang
Journal:  Medicine (Baltimore)       Date:  2021-07-23       Impact factor: 1.817

Review 6.  Immunobiology of hepatocarcinogenesis: Ways to go or almost there?

Authors:  Pavan Patel; Steven E Schutzer; Nikolaos Pyrsopoulos
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

Review 7.  Subsets of human natural killer cells and their regulatory effects.

Authors:  Binqing Fu; Zhigang Tian; Haiming Wei
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

Review 8.  NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma.

Authors:  Cheng Sun; Haoyu Sun; Cai Zhang; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2014-10-13       Impact factor: 11.530

9.  Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors.

Authors:  Vincent T Ma; Christopher T Su; Miriam Hu; Jeremy M G Taylor; Stephanie Daignault-Newton; Olesia Kellezi; Megan N Dahl; Miloni A Shah; Stephanie Erickson; Jessica Lora; Reema Hamasha; Alicia Ali; Sabrina Yancey; Leah Kiros; Hannah M Balicki; Daniel C Winfield; Michael D Green; Ajjai S Alva
Journal:  Urol Oncol       Date:  2021-01-23       Impact factor: 2.954

10.  Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination.

Authors:  Jiali Yu; Michael D Green; Shasha Li; Yilun Sun; Sara N Journey; Jae Eun Choi; Syed Monem Rizvi; Angel Qin; Jessica J Waninger; Xueting Lang; Zoey Chopra; Issam El Naqa; Jiajia Zhou; Yingjie Bian; Long Jiang; Alangoya Tezel; Jeremy Skvarce; Rohan K Achar; Merna Sitto; Benjamin S Rosen; Fengyun Su; Sathiya P Narayanan; Xuhong Cao; Shuang Wei; Wojciech Szeliga; Linda Vatan; Charles Mayo; Meredith A Morgan; Caitlin A Schonewolf; Kyle Cuneo; Ilona Kryczek; Vincent T Ma; Christopher D Lao; Theodore S Lawrence; Nithya Ramnath; Fei Wen; Arul M Chinnaiyan; Marcin Cieslik; Ajjai Alva; Weiping Zou
Journal:  Nat Med       Date:  2021-01-04       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.